jain.com

New convertible senior notes offering

Company: IREN

Subject kind
financing
Statement date
2025-12-02
Promised by
2025-12-08
Promised amount
2000.0 USD
Current status
verified

What the later record shows

Delivered on time · happened December 8, 2025

The offering closed at $1.15B of each series, meaning both $150M options were fully exercised. The notes were issued on December 8, 2025.

“IREN closed its offering of $1.15 billion aggregate principal amount of 0.25% convertible senior notes due 2032”
2025-12-07 · iren 8-K exhibit (ef20060782_ex99-1.htm) View cached copy (2026-09-24)Live source ↗
“On December 8, 2025, we issued $1.15 billion aggregate principal amount of the 2032 Convertible Notes and $1.15 billion aggregate principal amount of the 2033 Convertible Notes.”
2026-05-07 · IREN 10-Q filed 2026-05-08 View cached copy (2026-08-31)Live source ↗

Checked October 9, 2026 against filings, releases and reporting published after the claim was made. Quotes are verbatim from the linked documents.

The claim, verbatim

IREN is offering $1 billion of 0.25% convertible senior notes due 2032 and $1 billion of 1.00% convertible senior notes due 2033, with initial purchasers having options for up to $150 million additional of each

Source (primary)

iren 8-K exhibit (ny20060080x4_ex99-2.htm) (SEC EDGAR (8-K Ex), press_release)
View cached copy (2026-09-24)Live source ↗

Quote: “announced today the pricing of its previously announced private offering of $1 billion aggregate principal amount of 0.25% convertible senior notes due 2032 and $1 billion aggregate principal amount of 1.00% convertible senior notes due 2033, plus up to an additional $150 million aggregate principal amount of 2032 Notes and up to an additional $150 million aggregate principal amount of 2033 Notes”

How we checked this

Checked on October 12, 2026. The cited source supports every part of this claim.

The document announces the pricing of both $1 billion note series with these coupons and maturities. It also states the initial purchasers' options for up to $150 million more of each series.

Confirmed in the source:

What we did: Read our cached copy of SEC EDGAR (8-K Ex) (https://www.sec.gov/Archives/edgar/data/1878848/000114036125044095/ny20060080x4_ex99-2.htm) in full (8,771 characters, retrieved September 24, 2026) and checked each assertion in the claim against it.

Additional evidence

confirms iren 8-K exhibit (ny20060080x4_ex99-2.htm)

Quote: “announced today the pricing of its previously announced private offering of $1 billion aggregate principal amount of 0.25% convertible senior notes due 2032 and $1 billion aggregate principal amount of 1.00% convertible senior notes due 2033, plus up to an additional $150 million aggregate principal amount of 2032 Notes and up to an additional $150 million aggregate principal amount of 2033 Notes”

View cached copy (2026-09-24)Live source ↗

confirms IREN 10-Q filed 2026-05-08

Quote: “On December 8, 2025, we issued $1.15 billion aggregate principal amount of the 2032 Convertible Notes and $1.15 billion aggregate principal amount of the 2033 Convertible Notes.”

View cached copy (2026-08-31)Live source ↗

confirms iren 8-K exhibit (ef20060782_ex99-1.htm)

Quote: “IREN closed its offering of $1.15 billion aggregate principal amount of 0.25% convertible senior notes due 2032”

View cached copy (2026-09-24)Live source ↗

Record of changes

September 24, 2026 — stated
Automated extraction from the cited source. Recorded automatically from the cited source when it was published, then queued for evidence review.
September 25, 2026 — delayed
Automated extraction from the cited source. Recorded automatically from the cited source when it was published, then queued for evidence review.
October 9, 2026 — outcome unconfirmed
Automated extraction from the cited source. Recorded automatically from the cited source when it was published, then queued for evidence review.
October 9, 2026 — verified
Automated extraction from the cited source. Recorded automatically from the cited source when it was published, then queued for evidence review.